Search for: "Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.," Results 1 - 9 of 9
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Nov 2012, 5:00 am by Bexis
Merck Sharp & Dohme Corp., 807 N.W.2d 343, 347 (Mich. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Atripla (Emtricitabine) - US: District Court S D New York: Patent infringement suit filed following a Paragraph IV Certification: Merck, Sharp & Dohme Corp. et al. v. [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]